每经头条（nbdtoutiao）——多地出现"负电价"，既然卖电"不挣钱"，为何电厂不愿停机？ （记者 曾健辉） 每经AI快讯，圣湘生物（SH 688289，收盘价：21.57元）10月30日晚间发布公告称，圣湘生物科技股份 有限公司核心技术人员解亚平先生因个人原因申请辞任公司高级仪器研发总监等职务，辞任后将不再担 任公司任何职务。 2024年1至12月份，圣湘生物的营业收入构成为：体外诊断行业占比97.66%，其他业务占比2.34%。 截至发稿，圣湘生物市值为125亿元。 ...

Core Viewpoint - Shengxiang Bio reported a revenue of 1.244 billion yuan for the first nine months of 2025, reflecting a year-on-year growth of 20.49%, while net profit remained stable compared to the previous year [1] Group 1: Financial Performance - The company achieved a revenue of 1.244 billion yuan from January to September, marking a 20.49% increase year-on-year [1] - The net profit attributable to shareholders was 191 million yuan, with a non-recurring net profit of 157 million yuan, both remaining roughly unchanged from the same period last year [1] Group 2: Strategic Initiatives - Shengxiang Bio is implementing a "diagnosis and treatment integration" strategy, focusing on both external acquisitions and internal innovations to enhance product matrix and technical platform synergies [2] - The company has seen a rise in demand for respiratory products as the flu season approaches, with increased shipments and adequate preparations for testing needs [2] Group 3: Product Development - Multiple small joint detection products in the respiratory field have been approved this year, enriching the "6/3+X respiratory infection nucleic acid rapid detection scheme" [2] - The launch of the SUREXEVO 16A molecular POCT device in September aims to improve the efficiency and experience of respiratory pathogen detection [2] Group 4: Equipment and Automation - Shengxiang Bio has installed over 200 integrated machines this year, enhancing automation in the testing process [3] - The respiratory integrated machines have seen an addition of over 40 units, catering to the market demand during the flu season [3] Group 5: Expansion and Investment - The company is building a full-chain service capability, having acquired 100% of Zhongshan Haiji, which complements its pediatric infection diagnosis business [4] - Shengxiang Bio plans to establish a fund with partners to invest in AI medical applications and innovative medical technologies, with a target fundraising scale of 1 billion yuan [5] - The company intends to contribute 370 million yuan to the fund, representing a 37% stake, while other partners include state-owned entities [5]

圣湘生物科技股份有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 公司董事会及董事、高级管理人员保证季度报告内容的真实、准确、完整，不存在虚假记载、误 导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息 的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 圣湘生物科技股份有限公司 2025 年第三季度报告 证券代码：688289 证券简称：圣湘生物 单位:元 币种:人民币 一、主要财务数据 （一） 主要会计数据和财务指标 单位：元 币种：人民币 | | | 本报告期比 | | 年初至报告期 | | --- | --- | --- | --- | --- | | 项目 | 本报告期 | 上年同期增 | 年初至报告期末 | 末比上年同期 | | | | 减变动幅度 | | 增减变动幅度 | | | | (%) | | (%) | | 营业收入 | 375,518,504.36 | 18 ...

证券代码：688289 证券简称：圣湘生物 公告编号：2025-066 圣湘生物科技股份有限公司 关于与专业机构共同投资设立基金暨关联交易 的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 为进一步推动圣湘生物科技股份有限公司（以下简称"公司"）业务拓展 及产业链延伸，增强产业协同效应，完善公司在医疗领域的综合战略布局，公司 拟与长沙圣维荣泉创业投资有限公司（以下简称"圣维荣泉"）等合伙人共同出 资设立湖南金芙蓉圣湘生物基金合伙企业（有限合伙）（暂定名，以企业注册登 记机关最终核准登记的名称为准，以下简称"基金"或"合伙企业"）（以下简称 "本次交易"或"本次投资"）。其中，公司拟作为有限合伙人认缴出资人民币 37,000 万元，出资比例 37%。 本次交易构成关联交易，未构成重大资产重组。 本次交易事项已经公司第三届董事会 2025 年第四次临时会议及第三届 董事会独立董事专门会议 2025 年第二次会议审议通过，尚需提交公司股东会审 议，与该关联交易有利害关系的关联人将放弃行使在股东会上对该议案的投票 ...

（一）核心技术人员基本情况 证券代码：688289 证券简称：圣湘生物 公告编号：2025-068 圣湘生物科技股份有限公司 关于公司核心技术人员离职的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、核心技术人员离职的具体情况 圣湘生物科技股份有限公司（以下简称"公司"或"圣湘生物"）核心技术人员 解亚平先生因个人原因申请辞任公司高级仪器研发总监等职务，辞任后将不再担任公 司任何职务。其辞任不会对公司的技术研发、产品创新、核心竞争力与持续经营能力 产生不利影响，公司及董事会对其在任职期间为公司发展所做出的贡献表示衷心的感 谢。 解亚平先生，1981 年 9 月出生，中国国籍，无境外永久居留权，硕士研究生学历。 2007 年 3 月至 2013 年 6 月，任职于台达电子武汉研发中心，担任主任工程师主管职 务；2013 年 6 月至 2014 年 6 月，任职于武汉友芝友生物制药，担任高级经理职务； 2014 年 6 月至 2015 年 1 月，任职于中国平安，担任高级产品经理职务；2015 年 1 月 至 202 ...

Group 1 - The "International Talent Fair" in Shenzhen will feature over 20 listed companies and research institutions from Hunan, offering nearly 800 quality job positions, including 22 with salaries exceeding 1 million yuan, and the highest salary reaching 1.5 million yuan [2] - Companies participating include well-known firms such as Wanxing Technology, Weisheng Information, and Jingjia Microelectronics, with job roles spanning R&D, technology, marketing, management, and graduate training programs [2] - The recruitment event reflects the strong demand for talent from leading companies in Changsha, aligning salaries with coastal regions [2] Group 2 - AI talent is in high demand, with companies like Hunan Qilin Xinan and Tuo Wei Information offering positions such as large model algorithm engineers and embedded development engineers [3] - There is a notable demand for talent in overseas market expansion, with specific roles for international business and social media marketing personnel aimed at understanding overseas user habits [3]

Core Viewpoint - The article provides a comprehensive overview of significant fund establishment events in China, highlighting the growing trend of government-guided funds and private equity investments across various sectors, particularly in technology and innovation-driven industries [5]. Government-Backed Funds - Shenzhen Futian has established a 7 billion yuan AIC mother fund to support the "20+8" industrial development, focusing on key areas such as artificial intelligence and new energy materials [7]. - A 5 billion yuan national capital fund was launched in Shenzhen, targeting early-stage companies in computing power and semiconductor sectors [8]. - The Jiangsu Wuxi low-altitude economy and aerospace mother fund plans to invest in a 1 billion yuan sub-fund, focusing on low-altitude economy and commercial aerospace [8]. - Chengdu has launched a 1 billion yuan high-level talent innovation and entrepreneurship investment fund to support projects led by high-level talents [8]. Private Equity and Venture Capital Funds - The "Zhangzhou Gaoxin Runxin Health Fund" has been established with a total scale of 1 billion yuan, focusing on investments in the healthcare sector [9]. - Beijing Chaoyang District has set up a 500 million yuan data aggregation equity fund to promote the development of the data factor industry [10]. - The Anhui Wuwei City Sci-Tech sub-fund has completed registration with a total scale of 300 million yuan, focusing on cutting-edge industries [10]. - The Tianjin Angel Mother Fund is set to invest in a sub-fund with a target scale of 10 billion yuan, aiming to support early-stage investments [12]. Sector-Specific Funds - The "Taiyuan Semiconductor Industry Fund" has been established with a total scale of 1 billion yuan, focusing on key segments of the semiconductor industry [11]. - The "Fujian Cultural Tourism Digital Creation Fund" has been launched with a total scale of 3 billion yuan, aimed at supporting innovation in the cultural tourism sector [12]. - The "Shanghai Clinical Transformation Seed Investment Fund" has been established with an initial scale of 180 million yuan, focusing on medical innovation [13]. Notable Collaborations and Investments - The "Chongqing Chang'an Automobile Fund" has been set up with a total scale of 1 billion yuan, focusing on the smart and new energy vehicle industry [21]. - The "Tianjin Angel Mother Fund" plans to invest in a sub-fund with a total scale of 10 billion yuan, targeting early-stage investments in technology [12]. - The "Zhejiang Tian Tie Technology Fund" has been established with a total scale of 300 million yuan, focusing on solid-state battery projects [22].

Core Insights - The article highlights the impressive achievements of Changsha in developing industrial clusters, with 9 out of 13 clusters winning in the 2025 Hunan Province Industrial Cluster Competition [9] - Changsha's strategy focuses on building a national advanced manufacturing hub, emphasizing the cultivation of industrial chains and clusters as a core approach to enhance competitiveness [12][14] Industrial Cluster Development - The Ministry of Industry and Information Technology has announced the fourth batch of characteristic industrial clusters for small and medium-sized enterprises, with the inspection and testing instrument equipment cluster in Yuelu District included [9] - Industrial clusters are seen as a key indicator of regional manufacturing competitiveness, moving from simple geographic concentration to a more integrated approach involving collaboration across the industrial chain [14][15] Collaborative Mechanisms - Changsha has established a multi-level collaborative mechanism to enhance the development of industrial clusters, involving various stakeholders and ensuring clear responsibilities [16] - The city has implemented a "five-chain integration" and "five-leader linkage" mechanism to effectively consolidate resources such as industry, talent, innovation, capital, and supply [16] Policy Framework - A comprehensive policy system has been developed to support industrial cluster growth, including top-level planning, special policies, and supporting measures [19] - Specific policies have been introduced for different clusters, such as the "Changsha City Promotion of Engineering Machinery Industry Development Regulations," which provides legal support for innovation and market expansion [20] Ecosystem and Innovation - The competitiveness of industrial clusters is reflected in their ecosystem, characterized by a tiered structure, vibrant enterprises, and innovative capabilities [22] - Changsha's industrial ecosystem has attracted talent and facilitated collaboration among enterprises, enhancing the overall innovation landscape [24][23] Conclusion - The development of industrial clusters in Changsha represents a practical exploration of manufacturing upgrades, showcasing a model of collaborative, precise, and warm development [25]

Core Insights - The article highlights the successful development of specialized industrial clusters in Changsha, focusing on the city's strategic approach to avoid homogenization and instead cultivate unique strengths in specific sectors [9][12][22] Group 1: Industrial Clusters - Changsha's industrial clusters include high-end chemical raw materials, CNC grinding machines, and inspection and testing instruments, which have successfully carved out a niche in the national market [12][20] - The city has been recognized for its "specialized and refined" approach, leading to the inclusion of the Changsha inspection and testing instrument cluster in the national list of characteristic industrial clusters [9][12] Group 2: Strategic Development - The development strategy emphasizes leveraging local resources and market demands, with a focus on "precise selection of tracks" and "multi-dimensional market expansion" [14][22] - Changsha's approach includes government support and market cultivation, transforming potential advantages into competitive strengths [14][22] Group 3: Technological Innovation - Technological breakthroughs are central to the success of these industrial clusters, with initiatives like "revealing the list for tackling key technologies" and collaborative efforts among universities and enterprises [18][19] - Notable advancements include the development of key technologies in mass spectrometry and automated microscopy, which have filled significant gaps in the industry [18][19] Group 4: Market Expansion - The clusters are encouraged to penetrate both domestic and international markets, creating a "dual circulation" development pattern [19][20] - The high-end chemical raw materials cluster has established long-term partnerships with major pharmaceutical companies, achieving over 25% market share domestically [20] Group 5: Ecosystem Development - Changsha is enhancing its industrial ecosystem by extending supply chains and improving service systems, which contributes to both scale and quality improvements [21][22] - The city is fostering a collaborative environment among government, organizations, and professional institutions to support cluster development [21][22]

Core Points - The first "Home Fast Testing for Children" project in Hunan Province has been launched by Hunan Children's Hospital in collaboration with JD Health and Shengxiang Bio, providing at-home medical testing services for children [1][3] - The service model includes online ordering, home sampling, and rapid testing, aimed at reducing the burden on parents who need to take their children to hospitals for tests [1] - The initial service area covers an 8-kilometer radius around Hunan Children's Hospital, with test results available within an average of 3 hours after sampling [1] - The project is part of Hunan Children's Hospital's innovation in the "Internet + Healthcare" sector, addressing public health needs [1][3] - The hospital's platform also offers online follow-up consultations, allowing parents to book home nursing services easily [3] - The initiative aims to provide high-quality, convenient, and efficient health services for parents and children, enhancing their overall experience [3]